Incyte Stock Analysis

Incyte Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The book value of Incyte was currently reported as 23.72. The company has Price/Earnings To Growth (PEG) ratio of 0.13. Incyte recorded earning per share (EPS) of 6.41. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 1st of September 2000. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2094 people. To learn more about Incyte call William Meury at 302 498 6700 or check out https://www.incyte.com.

Incyte Investment Alerts

Incyte Largest EPS Surprises

View All Earnings Estimates

Incyte Environmental, Social, and Governance (ESG) Scores

Incyte Stock Institutional Investors

Note, although Incyte's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Incyte Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 19.64 B.

Incyte Profitablity

The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Management Efficiency

Incyte has return on total asset (ROA) of 0.1354 % which means that it generated a profit of $0.1354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3039 %, meaning that it created $0.3039 on every $100 dollars invested by stockholders. Incyte's management efficiency ratios could be used to measure how well Incyte manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Incyte's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.26 in 2026, whereas Return On Equity is likely to drop 0.18 in 2026. At this time, Incyte's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 1.6 B in 2026, despite the fact that Non Currrent Assets Other are likely to grow to (45.6 M).

Technical Drivers

As of the 12th of February 2026, Incyte retains the Standard Deviation of 2.34, market risk adjusted performance of (0.06), and Risk Adjusted Performance of (0.02). Incyte technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Incyte Price Movement Analysis

Incyte Insider Trading Activities

Incyte Outstanding Bonds

Incyte Predictive Daily Indicators

Incyte Corporate Filings

Incyte Forecast Models

Incyte's time-series forecasting models are one of many Incyte's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Incyte's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Incyte Bond Ratings

Incyte financial ratings play a critical role in determining how much Incyte have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Incyte's borrowing costs.

Incyte Debt to Cash Allocation

Incyte currently holds 69.43 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Incyte has a current ratio of 3.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Incyte's use of debt, we should always consider it together with its cash and equity.

Incyte Total Assets Over Time

Incyte Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Incyte uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Incyte Debt Ratio

0.95

It appears most of the Incyte's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Incyte's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Incyte, which in turn will lower the firm's financial flexibility.

Incyte Corporate Bonds Issued

Incyte Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Incyte prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Incyte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Incyte. By using and applying Incyte Stock analysis, traders can create a robust methodology for identifying Incyte entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Incyte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Incyte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Incyte stock analysis indicators help investors evaluate how Incyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Incyte shares will generate the highest return on investment. By understating and applying Incyte stock analysis, traders can identify Incyte position entry and exit signals to maximize returns.

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.